Wordt geladen...
Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
BACKGROUND: The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive description of country-specific health technology assessmen...
Bewaard in:
| Gepubliceerd in: | Orphanet J Rare Dis |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7545889/ https://ncbi.nlm.nih.gov/pubmed/33032634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01556-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|